The patient engagement engine for pharma portfolios

Behavior-driven digital engagement that helps pharmaceutical brands activate patients, improve outcomes, and scale support across therapies and markets.

Request a Demo

Explore Platform

IQVIA validated

13M+ patients supported

25+ pharma partners

150+ countries

up to 50x ROI

NIH published research

IQVIA validated

13M+ patients supported

25+ pharma partners

150+ countries

up to 50x ROI

NIH published research

IQVIA validated

13M+ patients supported

25+ pharma partners

150+ countries

up to 50x ROI

NIH published research

IQVIA validated

13M+ patients supported

25+ pharma partners

150+ countries

up to 50x ROI

NIH published research

Helping pharma connect with patients beyond the prescription

Medisafe helps brands extend support directly into patients' daily lives, activating patients earlier, keeping them engaged in therapy longer, and generating measurable outcomes across the treatment journey.

Request a Demo

Our Solutions

Designed for the full treatment ecosystem

For Pharma

Extend patient support programs into daily patient behavior and scale engagement across all brands and markets.

For Providers

Support patients between visits with digital tools that reinforce treatment plans and medication use.

For Patients

Simple digital experiences that help patients manage medications and navigate treatment.

Therapeutic Areas

Built for complex therapies

Medisafe works with pharmaceutical companies across complex and specialty therapies where sustained patient engagement is critical to outcomes.

Immunology

Inflammatory

Mental Health

Metabolic / GLP-1

Neurology

Oncology

Proven Results

Turning your program goals into achievable outcomes

Increase in medication adherence

15%

Increase in time on therapy

17%

Adherence lift in specialty therapies

43%

Reduction in claims events

34%

60-day retention

93%

Program ROI up to

Up to

50x

Validated through research with

IQVIA

Vanderbilt University / NIH

Komodo Health

Resource Library

Insights for pharma brand teams

Research, case studies, and perspectives on digital companions, adherence science, and patient engagement.

Research

Jun 12, 2026

IQVIA Research: The Link Between Digital Engagement and Therapy Persistence

Discover how an IQVIA study found Digital Companion users were significantly more likely to remain on therapy, providing new evidence for the impact of digital patient support.

Article

Jun 12, 2026

Personalized Digital Support for Chronic Disease Management

New insights reveal how personalized digital support can drive behavior change, improve medication adherence, and strengthen patient outcomes at scale.

Article

Jun 11, 2026

Understanding Gastroenterology Adherence Through Real-World Data

From routine disruptions to symptom management, discover the factors that shape gastroenterology therapy persistence.

Article

Jun 11, 2026

The Behavioral Drivers of Dermatology Treatment Adherence and Persistence

Nearly 30% of missed doses occur because patients don't believe treatment is necessary. Explore the behavioral drivers behind dermatology adherence.

Article

Jun 8, 2026

What 12+ Years of Adherence Data Reveals About Metabolic Therapy Persistence

New analysis of 12+ years of adherence data reveals the behavioral patterns, treatment factors, and support mechanisms that drive metabolic therapy persistence.

Article

Jun 8, 2026

How Real-World Data Improves Cardiovascular Therapy Persistence

New analysis of millions of managed doses uncovers the behavioral patterns, treatment complexities, and engagement trends shaping cardiovascular therapy persistence.

View All Resources

Bring patient engagement closer to the therapy

See how Medisafe helps pharmaceutical teams activate patients, improve adherence, and measure outcomes across their portfolio.

Request a Demo